Mitral Valve Stenosis Market Global Demand, Opportunities, Key Players and Forecast to 2032
The global mitral valve stenosis market is anticipated to grow significantly
over the forecast period. Mitral valve stenosis occurs when then the mitral
valve opening in the heart is narrowed. The mitral valve is located on the left
side of the heart between the two chambers namely the atrium and the ventricle.
In this condition, enough amount of blood does not flow through the mitral
valve. Scarring caused by rheumatic fever is considered to be the major cause
of mitral valve stenosis. The growing prevalence of heart diseases, increasing
occurrences of rheumatic fever, technological advancements coupled with the
introduction of novel mitral valves are anticipated to boost the growth of the
market during the assessment period. According to a study by researchers at the
Stanford University School of Medicine in 2017, it was found that more than
50,000 people in the United States undergo either aortic- or mitral valve
replacement surgery each year. On the other hand, the stringent government
regulation for drug and medical device approval and the high cost of mitral
valve surgeries may hamper the growth of the market.
Major Key
Players:
Some of Mitral Valve Stenosis Market Players are Medtronic Plc, Edward
Lifesciences, Boston Scientific Corporation, Abbott Laboratories, HighLife
Medical, Neovasc Inc., CryoLife, Inc., On-X Life Technologies, Inc., Braun
Melsungen AG, JenaValve Technology, Siemens Healthcare, and Micro Interventional
Devices, Inc.
Segment Analysis
The global mitral valve stenosis market has been
segmented into diagnostic tests, treatment, and end user.
The global market, on the basis of diagnostic tests,
has been segmented into electrocardiogram (ECG), transthoracic echocardiogram,
transesophageal echocardiogram, cardiac catheterization, and others.
The global market, on the basis of treatment, has
been segmented into medication and procedures. The medication segmented is
further classified into diuretics, blood thinners, beta blockers,
anti-arrhythmic drugs, and antibiotics. The procedures segment has been further
segmented into mitral valvuloplasty and mitral valve surgery. The mitral
surgery segment has been further classified into mitral valve repair and mitral
valve replacement. The procedures segment is anticipated to hold the largest
market share on the basis of treatment due to the growing number of companies
engaged in the development of medical devices for mitral valve stenosis.
The global market, by end user, has been segmented
into hospital & clinics, diagnostic centers, and others.
Regional Analysis
The market in the Americas is
expected to dominate the global mitral valve stenosis market. The market growth
in this region is majorly attributed to the presence of well-established
healthcare sector, rising prevalence of cardiac diseases, increasing preference
for minimally invasive surgeries, and growing healthcare expenditure. Europe is
anticipated to hold the second largest position in the global mitral valve
stenosis market. The market growth in this region is attributed to the
increasing prevalence of heart diseases and rising expenditure for the
healthcare sector. According to the UK factsheet August 2018 by the British
Heart Foundation, there are about 7 million people living with heart and
circulatory diseases in the UK. Asia-Pacific mitral valve stenosis market is
anticipated to be the fastest growing market. Rising burden of heart diseases,
improvement in clinical trial regulations, increasing preference for advanced
medical technologies, the rise in medical tourism, and increasing investments
in the healthcare sector are anticipated to drive the market growth in this
region. The Middle East & Africa has the least market share in the global
mitral valve stenosis market.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Comments
Post a Comment